Genetic test based risk stratification of sudden cardiac death and progression to end-stage heart failure in patients with dilated cardiomyopathy

Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新: 2020年4月21日

适应症

试验速览

暂无简介。

•1) or 2) with 3)
•1) Non-ischemic dilated cardiomyopathy with functional class II or more and persistently reduced left ventricular ejection fraction of 35% or less than 35% even after medical treatment at least 3 months. (regardless of ICD or CRT implantation)
•2) Patients with dilated cardiomyopathy who underwent ICD implantation as a secondary prevention purpose and left ventricular ejection fraction less than 50% even after medical treatment.
•3) Patients with age of 19 to 85 years who agree to study enrollment.

•1) Patients with expected survival duration is within 6 months due to cancer or cerebrovascular disease.
•2) Patients with dilated cardiomyopathy which related to neuromuscular disease
•3) Patients who can't understand study purpose due to cognitive dysfunction or unstable hemodynamic status.

发起方

Yonsei University Health System, Gangnam Severance Hospital